NeuroVive’s Board Members, Senior Executives and employees have subscribed to shares in the ongoing rights issue
In the current rights issue in NeuroVive, the Board, Senior Executives and employees have undertaken to subscribe for at least 1,778,995 shares equivalent to MSEK 2.4 which exceeds current holdings.The subscription period in the current rights issue in NeuroVive is ongoing until February 6, 2019 and is open to both existing and new investors. Read more about the rights issue at neurovive.emissioner.se. Prospectus (in Swedish), containing full terms and conditions, as well as application forms are available on NeuroVive's website www.neurovive.com, Stockholm Corporate Finance AB's